financetom
Business
financetom
/
Business
/
Zai Lab, Argenx Receive Chinese Approval for Neuromuscular Drug Vyvgart Hytrulo
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zai Lab, Argenx Receive Chinese Approval for Neuromuscular Drug Vyvgart Hytrulo
Nov 11, 2024 5:31 AM

08:03 AM EST, 11/11/2024 (MT Newswires) -- Zai Lab ( ZLAB ) and argenx (ARGX) said Monday that China's National Medical Products Administration has approved Vyvgart Hytrulo to treat chronic inflammatory demyelinating polyneuropathy, a neuromuscular disorder, in adult patients.

The companies said the approval is supported by trial data from a subgroup analysis of Chinese participants which showed a 69% reduction in the risk of relapse with Vyvgart Hytrulo, compared to placebo.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
WSFS Financial Q3 Core Earnings, Revenue Rise
WSFS Financial Q3 Core Earnings, Revenue Rise
Oct 23, 2025
05:03 PM EDT, 10/23/2025 (MT Newswires) -- WSFS Financial ( WSFS ) reported Q3 core earnings late Thursday of $1.40 per diluted share, up from $1.08 a year earlier. Analysts polled by FactSet expected $1.25. Net revenue for the three months ended Sept. 30 rose to $270.5 million from $267.7 million a year earlier. Analysts surveyed by FactSet expected $268.5...
Target plans to cut 1,800 corporate roles, WSJ reports
Target plans to cut 1,800 corporate roles, WSJ reports
Oct 23, 2025
Oct 23 (Reuters) - Target ( TGT ) plans to cut around 1,800 corporate roles as part of its strategy to reverse stagnant sales, the Wall Street Journal reported on Thursday, citing people familiar with the matter. As of February 1, the company had about 440,000 employees. The company's restructuring follows 11 consecutive quarters of weak or declining comparable sales,...
Western Union Q3 Adjusted Earnings Rise, Revenue Declines
Western Union Q3 Adjusted Earnings Rise, Revenue Declines
Oct 23, 2025
04:59 PM EDT, 10/23/2025 (MT Newswires) -- Western Union ( WU ) reported Q3 adjusted earnings late Thursday of $0.47 per diluted share, up from $0.46 a year earlier. Analysts polled by FactSet expected $0.43. Revenue for the three months ended Sept. 30 was $1.03 billion, down from $1.04 billion a year earlier. Analysts surveyed by FactSet expected $1.02 billion....
Baker Hughes beats third-quarter profit estimates
Baker Hughes beats third-quarter profit estimates
Oct 23, 2025
Oct 23 (Reuters) - Oilfield services provider Baker Hughes ( BKR ) surpassed Wall Street expectations for third-quarter profit on Thursday, helped by strength in its industrial and energy technology unit. The Houston-based company posted an adjusted profit of 68cents per share for the three months ended September 30, compared with analysts' estimates of 62 cents per share, according to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved